Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Long-Term Investments (2024 - 2025)

PAVmed has reported Long-Term Investments over the past 2 years, most recently at $34.1 million for Q4 2025.

  • For Q4 2025, Long-Term Investments rose 33.09% year-over-year to $34.1 million; the TTM value through Dec 2025 reached $34.1 million, up 33.09%, while the annual FY2025 figure was $34.1 million, 33.09% up from the prior year.
  • Long-Term Investments for Q4 2025 was $34.1 million at PAVmed, up from $31.6 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $46.6 million in Q1 2025 and troughed at $25.6 million in Q4 2024.